2022
Advances in molecular infectious diseases testing in the time of COVID-19
Peaper DR, Kerantzas CA, Durant TJS. Advances in molecular infectious diseases testing in the time of COVID-19. Clinical Biochemistry 2022, 117: 94-101. PMID: 35181291, PMCID: PMC8843810, DOI: 10.1016/j.clinbiochem.2022.02.005.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsClinical Laboratory TechniquesCommunicable DiseasesCOVID-19COVID-19 TestingHumansPandemicsSARS-CoV-2ConceptsSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Infectious diseasesRespiratory syndrome coronavirus 2Syndrome coronavirus 2COVID-19Public health needsCoronavirus 2Health needsDiagnostic testingCoronavirus diseaseLaboratory responseWidespread testingDiseaseCOVID-19 pandemicLaboratory medicineSample collectionPandemicTestingChallenging eventsDiagnostic manufacturers
2021
Centralized vs Decentralized Molecular Infectious Disease Testing
Campbell S, Anderson N, Babady E, Durant TJS, Fisher A, Moore N. Centralized vs Decentralized Molecular Infectious Disease Testing. Clinical Chemistry 2021, 67: 713-719. PMID: 33517379, DOI: 10.1093/clinchem/hvaa318.Commentaries, Editorials and Letters